Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.

Authors :: Leso A
Bihaqi SW
Masoud A
Chang JK
Lahouel A
Zawia N
Source :: Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2019 Oct; Vol. 244 (13), pp. 1062-1069. Date of Electronic Publication: 2019 Aug 26.
Publication Year :: 2019

Subjects :: Alzheimer Disease pathology
Alzheimer Disease physiopathology
Amyloid beta-Peptides metabolism
Animals
Cell Line, Tumor
Cyclin-Dependent Kinase 5 metabolism
Cyclooxygenase 2 metabolism
Disease Models, Animal
Frontal Lobe drug effects
Frontal Lobe pathology
Humans
Memory drug effects
Mice, Knockout
Treatment Outcome
ortho-Aminobenzoates pharmacology
tau Proteins genetics
Alzheimer Disease drug therapy
ortho-Aminobenzoates therapeutic use
tau Proteins deficiency

Full Text Access

Tools